April 18, 2011

The Food and Drug Administration has approved a drug made by Genentech for treating a rare and severe form of arthritis that affects children, Genentech said.

February 11, 2011

Genentech, a subsidiary of Roche, reported that its eye drug helped improve vision in patients suffering from a complication caused by diabetes.

February 9, 2011

Women with ovarian cancer who received a drug made by Genentech lived longer without their disease becoming worse, according to a late-stage clinical trial.

January 19, 2011

Drug maker Genentech is hoping to keep a breast cancer treatment on the market as the Food and Drug Administration considers whether to revoke its approval for the disease, according to published reports.

January 19, 2011

Patients taking an investigational drug made by Genentech for advanced skin cancer fared better than those receiving standard treatments, according to results of a late-stage clinical trial announced Wednesday.

January 18, 2011

Generic drug maker Sandoz has started a mid-stage clinical trial of a monoclonal antibody used to treat cancer and autoimmune disease, the company said.

January 14, 2011

Biotech company Genentech advised consumers to avoid alcohol prep pads distributed with some of its drugs due to possible contamination.

January 6, 2011

The Food and Drug Administration has expanded the approved usage of a drug made by Genentech, part of Swiss drug maker Roche.

January 6, 2011

A U.S. biotech company plans to develop a biosimilar of a monoclonal antibody used to treat cancers and autoimmune disorders.

December 16, 2010

Just a few months after a Food and Drug Administration advisory committee recommended limiting the use of a Genentech drug designed to treat breast cancer, the regulatory agency is looking to revoke the approval altogether.

December 15, 2010

Procter & Gamble on Tuesday afternoon named a healthcare veteran to its board. Susan Desmond-Hellmann, 53, chancellor of the University of California, San Francisco was named to the board, effective Dec. 13.

December 9, 2010

An investigational treatment for lung cancer made by Boehringer Ingelheim Pharmaceuticals extended patients’ survival by more than four months, according to results of a late-stage clinical trial announced Thursday.

December 6, 2010

A biotech drug made by Roche subsidiary Genentech allowed patients with a blood cancer, who did not show symptoms, to delay starting on chemotherapy or radiotherapy, and decreased the risk of their disease worsening, according to results of a late-stage clinical trial.

October 20, 2010

The Food and Drug Administration has approved a biotech drug for treating cancer of the...

September 19, 2010

Biotech company Genentech has amended its application to the Food and Drug Administration seeking an...

September 8, 2010

NEW YORK British drug maker GlaxoSmithKline and biotech company Genmab have started a late-stage trial...

August 26, 2010

Pfizer reported mixed results this week in a late-stage clinical trial combining two drugs in...

July 20, 2010

A Food and Drug Administration advisory committee has voted to recommend limiting use of a...

June 22, 2010

The Food and Drug Administration has approved a drug made by Genentech for treating a...

June 15, 2010

Drug maker OXiGENE has finished enrolling patients for a mid-stage clinical trial of a lung...

June 9, 2010

Bayer HealthCare Pharmaceuticals trade relations director Michael Catanio received the Nexus Award for Lifetime Achievement...

June 7, 2010

Japanese drug maker Astellas Pharma has completed its acquisition of OSI Pharmaceuticals, Astellas said Tuesday....

May 18, 2010

The Food and Drug Administration has approved a new biotech drug made by Roche U.S....

May 16, 2010

Japanese drug maker Astellas Pharma will acquire U.S.-based OSI Pharmaceuticals for $4 billion, the two...